Spero Therapeutics, Inc. (NASDAQ:SPRO) Q4 2020 Earnings Conference Call March 11, 2021 4:30 PM ET Company Participants Sharon Klahre – Vice President of Investor Relations and Strategic Finance Ankit Mahadevia – Chief Executive Officer David Melnick – Chief Medical Officer Cristina Larkin – Chief Operating Officer Sath Shukla – Chief Financial Officer Conference Call Participants Lyla Youssef – Cowen & Company Louise Chen – Cantor Fitzgerald Kevin DeGeeter – Oppenheimer Esther Hong – Berenberg Ram Selvaraju ...